NCT01981486View on ClinicalTrials.gov

A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Migraine
Interventions
DRUG

Placebo Tablets

BID modified-release tablets

DRUG

PF-05180999 Tablets

BID modified-release tablets (20 to 240 mg BID)

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01981486 - A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults | Biotech Hunter | Biotech Hunter